To tailor cancer therapies to individual patients, Moderna, BioNTech and other companies are rethinking how they optimize ...

An analysis of patient records suggests that mRNA covid-19 vaccines boost the immune response to cancerous tumours when given ...

RNA vaccines are quick and easy to make, while virus-like nanoparticles produce a stronger immune response. Now, the two ...

Covid vaccines may come with a tantalizing benefit that has nothing to do with the virus they’re designed to protect against: ...

A team led by Neil King, a biochemistry professor at the University of Washington School of Medicine, is now exploring a new ...

A team of researchers from Yong Loo Lin School of Medicine, National University of Singapore (NUS Medicine) and Tsinghua ...

Patients with advanced lung or skin cancer who received a COVID-19 mRNA vaccine within 100 days of starting immunotherapy ...

CAMBRIDGE, MA / ACCESS Newswire / October 19, 2025 / Moderna, Inc. (NASDAQ:MRNA) today announced data regarding two of its ...

Moderna faces significant uncertainty ahead of Q3 earnings, with heavy reliance on COVID vaccine revenues and limited ...

By casting doubt about the promise of mRNA tech, RFK Jr. is slowing progress toward highly effective therapies that could ...

October 16, 2025 / Moderna, Inc. (NASDAQ:MRNA) today announced that it will host a live conference call and webcast at 8:00 a ...

Vaccine Linked to Longer Survival in Cancer Patients,” found that people with advanced lung or skin cancer who received an ...